scholarly journals Peri-Operative Management of a Patient with Sickle Cell Disease for Total Hip Replacement: Case Report

2021 ◽  
Vol 02 (04) ◽  
Author(s):  
Bhuvanshyam J Bhaktavatsalam ◽  
Divya Iyer ◽  
Alexander Marfin
2002 ◽  
Vol 26 (3) ◽  
pp. 157-161 ◽  
Author(s):  
Al-Mousawi F. ◽  
Malki A. ◽  
Al-Aradi A. ◽  
Al-Bagali M. ◽  
Al-Sadadi A. ◽  
...  

SICOT-J ◽  
2018 ◽  
Vol 4 ◽  
pp. 22 ◽  
Author(s):  
Udo Ego Anyaehie ◽  
Gabriel Okey Eyichukwu ◽  
Cajetan Uwatoronye Nwadinigwe ◽  
Amechi Uchenna Katchy

Introduction: Total hip replacement (THR) surgery is still evolving in Nigeria with increasing awareness as more cases are being done. This has attraction for individuals who hitherto had no solutions for their hip pathologies. These are mostly complex primary hips which present challenging technical difficulties with increased risk of complications, thus requiring detailed planning to ensure successful operation. This work aims to present the pattern of complex primary hips presenting for THR, the challenges and complications. Methodology: Data collected over a seven year period, of patients who presented for THR, were analyzed for age, sex, diagnosis, type of hip, complications, duration of surgery, blood loss and transfusions, challenges and outcome. Results: Fifty-nine (43.4%) of the 136 cases of THR done were complex primary hip replacement surgeries. Avascular necrosis of femoral head amongst sickle cell disease patients (23.7%) was the commonest cause of complex primary hips in our series. Most of them had absent/tight medullary canals. This is followed by old unreduced hip dislocation and non-united hip fractures with an incidence of 10.1% each. The major peri operative complication noted was calcar split in 10 patients (16.9%) Discussion: Sickle cell disease patients presented more with complex primary hips and the commonest difficulty was recreating medullary canals. Increased operation time and blood loss alongside technical difficulties should be anticipated and measures put in place to avert complications.


2015 ◽  
Vol 26 (2) ◽  
pp. 186-192 ◽  
Author(s):  
Christopher M. Jack ◽  
Jo Howard ◽  
Emad S. Aziz ◽  
Rachel Kesse-Adu ◽  
Marcus J. Bankes

PEDIATRICS ◽  
1974 ◽  
Vol 54 (4) ◽  
pp. 438-441
Author(s):  
Gerald Erenberg ◽  
Steven S. Rinsler ◽  
Bernard G. Fish

Four cases of lead neuropathy in children with hemoglobin S-S or S-C disease are reported. Neuropathy is a rare manifestation of lead poisoning in children, and only ten other cases have been well documented in the pediatric literature. The last previous case report of lead neuropathy was also in a child with hemoglobin S-S disease. The neuropathy seen in the children with sickle cell disease was clinically similar to that seen in the previously reported cases in nonsicklers, but differed in both groups from that usually seen in adult cases. It is, therefore, postulated that children with sickle cell disease have an increased risk of developing neuropathy with exposure to lead. The exact mechanism for this association remains unknown, but in children with sickle cell disease presenting with symptoms or signs of peripheral weakness, the possibility of lead poisoning must be considered.


Sign in / Sign up

Export Citation Format

Share Document